GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » 3-Year EPS without NRI Growth Rate

Sailong Pharmaceutical Group Co (SZSE:002898) 3-Year EPS without NRI Growth Rate : 70.50% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co 3-Year EPS without NRI Growth Rate?

Sailong Pharmaceutical Group Co's EPS without NRI for the three months ended in Mar. 2024 was ¥0.02.

During the past 3 years, the average EPS without NRI Growth Rate was 70.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of Sailong Pharmaceutical Group Co was 70.50% per year. The lowest was -45.00% per year. And the median was 1.60% per year.


Competitive Comparison of Sailong Pharmaceutical Group Co's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sailong Pharmaceutical Group Co's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's 3-Year EPS without NRI Growth Rate falls into.



Sailong Pharmaceutical Group Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Sailong Pharmaceutical Group Co  (SZSE:002898) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Sailong Pharmaceutical Group Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Sailong Pharmaceutical Group Co (SZSE:002898) Business Description

Traded in Other Exchanges
N/A
Address
No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015
Zhuhai Sailong Pharmaceutical Co Ltd is the pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.

Sailong Pharmaceutical Group Co (SZSE:002898) Headlines

No Headlines